Skip to main content
Fig. 3 | Diagnostic Pathology

Fig. 3

From: Erythroid variant evolving from chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitors: a rare case report

Fig. 3

Comparison of diagnostic criteria for “CML-AP” in the 2017 WHO (left row) [17], “high risk CP-CML” according to 5th WHO edition (middle row) [19], and simplified “AP-CML” in the 2022 ICC (right row) [20]. AP = accelerated phase; CP = chronic phase; ELTS = The EUTOS long-term survival score; ACA = additional cytogenetic abnormalities; TKI = tyrosine kinase inhibitor

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us